Seguir
Fred Hirsch
Fred Hirsch
Mount Sinai Health System, New York
Dirección de correo verificada de mssm.edu
Título
Citado por
Citado por
Año
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
59292011
The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ...
Journal of thoracic oncology 10 (9), 1243-1260, 2015
44992015
Lung cancer: current therapies and new targeted treatments
FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, ...
The Lancet 389 (10066), 299-311, 2017
28322017
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non–small-cell lung cancer
F Cappuzzo, FR Hirsch, E Rossi, S Bartolini, GL Ceresoli, L Bemis, ...
Journal of the National Cancer Institute 97 (9), 643-655, 2005
19662005
Epidermal growth factor receptor in non–small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch, M Varella-Garcia, PA Bunn Jr, MV Di Maria, R Veve, ...
Journal of clinical oncology 21 (20), 3798-3807, 2003
17652003
Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American …
NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ...
Archives of pathology & laboratory medicine 142 (3), 321-346, 2018
14882018
PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project
FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ...
Journal of Thoracic Oncology 12 (2), 208-222, 2017
12772017
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non–small-cell lung cancer
FR Hirsch, M Varella-Garcia, PA Bunn Jr, WA Franklin, R Dziadziuszko, ...
Journal of clinical oncology 24 (31), 5034-5042, 2006
9162006
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
DB Doroshow, S Bhalla, MB Beasley, LM Sholl, KM Kerr, S Gnjatic, ...
Nature reviews Clinical oncology 18 (6), 345-362, 2021
8222021
Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer
MD Hellmann, MK Callahan, MM Awad, E Calvo, PA Ascierto, A Atmaca, ...
Cancer cell 33 (5), 853-861. e4, 2018
8102018
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology
FR Hirsch, WA Franklin, AF Gazdar, PA Bunn Jr
Clinical Cancer Research 7 (1), 5-22, 2001
8102001
A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer
DL Rimm, G Han, JM Taube, SY Eunhee, JA Bridge, DB Flieder, R Homer, ...
JAMA oncology 3 (8), 1051-1058, 2017
7522017
PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project
MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ...
Journal of Thoracic Oncology 13 (9), 1302-1311, 2018
6912018
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
6832017
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
CH Chung, K Ely, L McGavran, M Varella-Garcia, J Parker, N Parker, ...
Journal of clinical oncology 24 (25), 4170-4176, 2006
6762006
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with …
FR Hirsch, M Varella-Garcia, J McCoy, H West, AC Xavier, P Gumerlock, ...
J clin oncol 23 (28), 6838-6845, 2005
6662005
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
6132017
Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC
C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ...
Journal of thoracic oncology 13 (9), 1248-1268, 2018
6042018
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines
SE Witta, RM Gemmill, FR Hirsch, CD Coldren, K Hedman, L Ravdel, ...
Cancer research 66 (2), 944-950, 2006
5972006
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
JP Neijt, SA Engelholm, MK Tuxen, PG Sørensen, M Hansen, C Sessa, ...
Journal of Clinical Oncology 18 (17), 3084-3092, 2000
5962000
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20